{"id":2898,"date":"2026-03-27T16:12:51","date_gmt":"2026-03-27T15:12:51","guid":{"rendered":"https:\/\/aisvision.com\/es\/?p=2898"},"modified":"2026-03-27T16:20:54","modified_gmt":"2026-03-27T15:20:54","slug":"control-de-calidad-de-etiquetas-en-viales-farmaceuticos-como-garantizar-el-cumplimiento-normativo","status":"publish","type":"post","link":"https:\/\/aisvision.com\/ca\/2026\/03\/27\/control-qualitat-etiquetes-vials-farmaceutics\/","title":{"rendered":"Control de qualitat d&#8217;etiquetes en vials farmac\u00e8utics: com garantir el compliment normatiu"},"content":{"rendered":"<p><\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">En el sector farmac\u00e8utic, l&#8217;etiquetatge de vials no \u00e9s nom\u00e9s una q\u00fcesti\u00f3 est\u00e8tica: \u00e9s un requisit cr\u00edtic de seguretat, tra\u00e7abilitat i compliment regulatori. Un error en l&#8217;etiqueta pot suposar la retirada d&#8217;un lot, sancions regulat\u00f2ries o, en el pitjor cas, un risc per al pacient.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Per qu\u00e8 \u00e9s tan important el control de qualitat en l&#8217;etiquetatge de vials?<\/strong><\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Els vials farmac\u00e8utics contenen medicaments injectables, vacunes o principis actius d&#8217;alt valor.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">La seva etiqueta ha d&#8217;incloure informaci\u00f3 precisa: nom del producte, concentraci\u00f3, n\u00famero de lot, data de caducitat i codis de tra\u00e7abilitat (com el codi DataMatrix exigit per la normativa europea FMD\/DSCSA). Qualsevol desviaci\u00f3 \u2014 text borr\u00f3s, etiqueta mal posicionada, codi il\u00b7legible \u2014 pot tenir conseq\u00fc\u00e8ncies greus.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>Inspecci\u00f3 360\u00b0 d&#8217;etiquetes: la soluci\u00f3 m\u00e9s completa<\/strong> Els sistemes d&#8217;inspecci\u00f3 visual a 360\u00b0 permeten verificar la integritat total de l&#8217;etiqueta en cada vial, a alta velocitat i sense interrompre la l\u00ednia de producci\u00f3. Aquests sistemes comproven de manera autom\u00e0tica:<\/p>\n<p>Pres\u00e8ncia i posici\u00f3 correcta de l&#8217;etiqueta<\/p>\n<p>Llegibilitat del text i impressi\u00f3<\/p>\n<p>Verificaci\u00f3 i lectura de codis de barres i DataMatrix<\/p>\n<p>Detecci\u00f3 d&#8217;arrugues, bombolles o despegaments<\/p>\n<p>Compliment de l&#8217;est\u00e0ndard farmac\u00e8utic (GMP, FDA, EMA)<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"><strong>AIS REV 360 Compact Pharma: inspecci\u00f3 d&#8217;etiquetes per a vials farmac\u00e8utics<\/strong> L&#8217;AIS REV Compact Pharma \u00e9s un inspector d&#8217;etiquetes a 360\u00b0 dissenyat espec\u00edficament per a entorns de producci\u00f3 farmac\u00e8utica. Compacte, robust i de f\u00e0cil integraci\u00f3 en l\u00ednies existents, ofereix una inspecci\u00f3 completa de cada vial amb zero falsos negatius.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Invertir en un sistema de control de qualitat d&#8217;etiquetes \u00e9s invertir en la reputaci\u00f3 de la seva empresa, en la seguretat del pacient i en el compliment normatiu. Amb la tecnologia adequada, \u00e9s possible assolir el 100% d&#8217;inspecci\u00f3 sense sacrificar la velocitat de producci\u00f3.<\/p>\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>En el sector farmac\u00e8utic, l&#8217;etiquetatge de vials no \u00e9s nom\u00e9s una q\u00fcesti\u00f3 est\u00e8tica: \u00e9s un requisit cr\u00edtic de seguretat, tra\u00e7abilitat i compliment regulatori. Un error en l&#8217;etiqueta pot suposar la retirada d&#8217;un lot, sancions regulat\u00f2ries o, en el pitjor cas, un risc per al pacient. Per qu\u00e8 \u00e9s tan important el control de qualitat en [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":2899,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[3],"tags":[],"class_list":["post-2898","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-eventos"],"acf":[],"views":484,"_links":{"self":[{"href":"https:\/\/aisvision.com\/ca\/wp-json\/wp\/v2\/posts\/2898","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aisvision.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aisvision.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aisvision.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/aisvision.com\/ca\/wp-json\/wp\/v2\/comments?post=2898"}],"version-history":[{"count":5,"href":"https:\/\/aisvision.com\/ca\/wp-json\/wp\/v2\/posts\/2898\/revisions"}],"predecessor-version":[{"id":2904,"href":"https:\/\/aisvision.com\/ca\/wp-json\/wp\/v2\/posts\/2898\/revisions\/2904"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aisvision.com\/ca\/wp-json\/wp\/v2\/media\/2899"}],"wp:attachment":[{"href":"https:\/\/aisvision.com\/ca\/wp-json\/wp\/v2\/media?parent=2898"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aisvision.com\/ca\/wp-json\/wp\/v2\/categories?post=2898"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aisvision.com\/ca\/wp-json\/wp\/v2\/tags?post=2898"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}